US 11707454
Topical roflumilast formulation having antifungal properties
granted A61KA61K31/137A61K31/201
Quick answer
US patent 11707454 (Topical roflumilast formulation having antifungal properties) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCUTIS BIOTHERAPEUTICS, INC.
- Grant date
- Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/137, A61K31/201, A61K31/27, A61K31/343